Science 37 and CMIC HOLDINGS Co., Ltd. (“CMIC”) have announced a partnership to further decentralized clinical trials (DCTs). In this collaboration, CMIC will use Science 37’s clinical trial Operating System and its end-to-end technology platform to help orchestrate workflows, generate evidence, and blend data for global decentralized studies.
Science 37 and 3H Medi Solution Inc., also have announced a collaboration to further decentralized clinical trials. In this partnership, 3H Medi Solution will use Science 37’s clinical trial Operating System with its end-to-end technology platform for eConsent, electronic data capture, patient management, telemedicine and mobile nurse operations.
Through these partnerships, CMIC and 3H Medi Solution become part of the Science 37 CRO Certified network.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.